Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Vicus Therapeutics

Vicus Therapeutics
2005 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$755K LATEST DEAL AMOUNT
Description

Provider of cancer treatment therapies. The company offers lung cancer treatment therapies for advanced stage cancer patients.

Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 55 Madison Avenue
  • Suite 400
  • Morristown, NJ 07960
  • United States

+1 (973) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Vicus Therapeutics’s full profile, request a free trial.

Vicus Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 12-Aug-2010 $755K 00.000 Completed Startup
3. Angel (individual) 09-Jul-2009 00000 00.000 Completed Startup
2. Angel (individual) 06-Aug-2008 $800K $1.6M Completed Startup
1. Angel (individual) 27-Jul-2007 $800K $800K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Vicus Therapeutics Executive Team (2)

Name Title Board
Seat
Contact
Info
John Maki President, Board Member & Chief Executive Officer
Newell Bascomb Ph.D Chief Operating Officer & Executive Vice President

Vicus Therapeutics Board Members (3)

Name Representing Role Since Contact
Info
Arch Meredith Self Board Member 000 0000
Charles Crocker Self Board Member 000 0000
Jim Erbs Vicus Therapeutics Board Member 000 0000